Deutsche Bank’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,257
Closed -$31.9K 3766
2026
Q1
$31.9K Hold
16,257
﹤0.01% 3513
2025
Q4
$44.1K Hold
16,257
﹤0.01% 3473
2025
Q3
$68.8K Hold
16,257
﹤0.01% 3396
2025
Q2
$81K Sell
16,257
-13,123
-45% -$57K ﹤0.01% 3324
2025
Q1
$130K Hold
29,380
﹤0.01% 3123
2024
Q4
$137K Buy
+29,380
New +$161K ﹤0.01% 3214
2021
Q4
Sell
-40,006
Closed -$1.64M 4303
2021
Q3
$1.64M Buy
40,006
+15,850
+66% +$575K ﹤0.01% 2258
2021
Q2
$870K Buy
+24,156
New +$891K ﹤0.01% 2861
2021
Q1
Sell
-1,462
Closed -$59K 4582
2020
Q4
$59K Buy
+1,462
New +$67.2K ﹤0.01% 4071

Other funds holding GDRX

Deutsche Bank's GDRX Position: Q2 2026 in Review

Deutsche Bank sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 16,257 shares — an estimated $31.9K sold.

Deutsche Bank first reported a position in GDRX in Q4 2020 and held it in 9 quarters. The position peaked at $1.64M in Q3 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Deutsche Bank reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Deutsche Bank sold 16,257 GoodRx Holdings shares in Q2 2026, an estimated $31.9K.
  • Deutsche Bank first reported a position in GoodRx Holdings in Q4 2020 and held it in 9 quarters.
  • Deutsche Bank's GoodRx Holdings position peaked at $1.64M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.